|
|
Intervention effect analysis of clinical pharmacists on rational use of adjuvant drugs in orthopedic inpatients |
LIN Xue-feng PAN Yan-ting |
Clinical Pharmaceutics Room,Department of Pharmacy,Pingshan District People′s Hospital of Shenzhen City,Guangdong Province,Shenzhen 518118,China |
|
|
Abstract Objective To analyze the interaction effect of clinical pharmacists on rational use of adjuvant drugs in orthopedic inpatients,and to promote the rational use of adjuvant drugs for orthopedic inpatients in our hospital.Methods The medical records of the orthopaedics department of our hospital from January to June 2017 (before the intervention) were selected,and the auxiliary medication orders were specially reviewed.The typical problems found were summarized and measures were taken to intervene.The hospital orders of orthopaedic auxiliary drugs from July to December 2017 (after the intervention) were collected and reviewed.The reasonable utilization rate of auxiliary drugs,the reasonable rate of indications,the reasonable rate of usage and dosage,the reasonable rate of solvent,the reasonable rate of course of treatment and the reasonable rate of combined drugs were used as inspection indicators.The changes of the above indicators before and after the intervention were analyzed,and whether there was statistical significance was analyzed,so as to evaluate the intervention effect.Results Before the intervention,489 medical records of orthopaedics patients were treated with adjuvant drugs,492 medical records of orthopaedics patients were treated with adjuvant drugs after the intervention.After the intervention,the reasonable utilization rate of drugs (85.37%),the reasonable rate of indications (93.09%),the reasonable rate of usage and dosage (95.93%),the reasonable rate of menstruum (93.90%),the reasonable rate of course of treatment (89.84%) and the reasonable rate of combined drugs (94.30%)were all higher than those before the intervention (41.72%,81.60%,83.23%,85.89%,83.64%,85.89%),respectively,with statistically significant differences (P<0.05).Conclusion After the intervention of clinical pharmacists,the irrational use of auxiliary drugs for orthopedic inpatients in our hospital has been significantly improved,reducing the risks of clinical drug use and the economic burden of patients,and making drug use more rational.
|
|
|
|
|
[1] |
彭康,王萍.某三甲医院2014~2016年辅助用药使用分析[J].中国药师,2017,20(11):2009-2012.
|
[2] |
夏海建,黄富宏,李蕾,等.某院2014年辅助用药分析[J].中国药业,2016,25(21):79-82.
|
[3] |
钟敏涛,韩爽,张璐,等.基于德尔菲法专家调研的我国医疗机构辅助用药研究[J].中国医院药学杂志,2016,36(19):1621-1624.
|
[4] |
韩爽,钟敏涛,李锦,等.我国辅助用药应用现状及管理对策初探[J].中国药学杂志,2016,51(8):678-682.
|
[5] |
徐媛,徐蔚蔚,李扬.辅助用药临床应用情况分析[J].中国
|
[5] |
徐媛,徐蔚蔚,李扬.辅助用药临床应用情况分析[J].中国医院药学杂志,2017,37(1):73-75.
|
[6] |
王静,陈伯华,吉顺莉,等.专项点评干预对我院辅助用药合理应用的影响[J].实用药物与临床,2018,21(5):573-577.
|
[7] |
付联群.超剂量使用红花注射液引起的不良反应病例分析[J].中国中西医结合杂志,2012,32(1):124-125.
|
[8] |
王静,郭宇姝,游亮,等.某院住院药房辅助用药使用情况分析[J].解放军药学学报,2017,33(5):467-471.
|
[9] |
万正兰,林光花.抗肿瘤药超说明书使用调查分析[J].中国医院药学杂志,2013.33(12):1003-1004.
|
[10] |
拾倩,于丹.从我院门诊中成药处方存在的问题分析临床中成药使用的合理性[J].江苏中医药,2016,48(3):75-77.
|
[11] |
魏娜,于莉,尹茂山.济南军区总医院2015年7~12月临床辅助用药使用分析[J].中国药事,2016,30(8):821-826.
|
[12] |
郭剑伟,黄兴富,法艳梅,等.2015~2016年曲靖市第一人民医院注射用辅助用药的使用情况分析[J].现代药物与临床,2018,33(4):955-960.
|
[13] |
陈金星.加强临床辅助用药管理的体会[J].北方药学,2016,13(10):158-159.
|
[14] |
何蒇,冯焕村,周陈亮.某院辅助用药医嘱点评工作情况分析[J].中国医药导报,2016,13(26):136-139.
|
[15] |
黄光英,蔡小利,钱青.我院急诊科2014年l~6月辅助治疗药物应用分析[J].中国药房,2015,26(11):1470.
|
[16] |
孙鸿铃.某院2016年住院患者辅助用药医嘱单分析[J].中国药物与临床,2017,17(8):1132.
|
|
|
|